← Back
$HRTX All transactions

HERON THERAPEUTICS, INC. /DE/

A

$ Value

$0

Shares

188,315

Price

$0

Filed

Feb 3

Insider

Name

Hensley Mark Earl

Title

Chief Operating Officer

CIK

0002065816

Roles

Officer

Transaction Details

Transaction Date

2026-01-30

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

188,315

Footnotes

Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. | On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein. | Performance stock units ("PSUs") convert into common stock on a one-for-one basis. | On January 30, 2026, the Reporting Person was granted 188,314 PSUs which vest upon the following time-based vesting schedule: the PSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant, subject to satisfaction of the milestone-based vesting condition: the applicable percentage of the PSUs vesting based on a net product sales revenue target for the fiscal year ending December 31, 2026 as reported in the Issuer's Form 10-K. The full amount of the PSUs granted to the Reporting Person is reflected herein.

Filing Info

Accession No.

0001193125-26-034625

Form Type

4

Issuer CIK

0000818033

Hensley Mark Earl's History

Date Ticker Type Value
2026-01-30 HRTX A $0
2026-01-30 HRTX A $0
2025-05-06 HRTX A $0

Other Insiders at HRTX (90d)

Insider Bought Sold Last
Forbes William P
EVP, Chief Development Officer
2026-04-19
Collard Craig A
Chief Executive Officer
2026-04-19
Johnson Craig A 2026-01-30
Duarte Ira
EVP, Chief Financial Officer
2026-04-19
Christian Waage 2026-01-30
Kaseta Michael 2026-01-30
Dissanaike Sharmila 2026-01-30
Morgan Adam 2026-01-30
Hensley Mark Earl
Chief Operating Officer
2026-01-30
Cusack Thomas 2026-01-30